“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Unicorns Hunt for Talent Among Silicon Valley’s Giants
Report: Assad agreed to quit on own conditions, US refused
Ron Paul: Yellen likely frontrunner in Fed race
Fannie Mae and Freddie Mac to begin merging operations
Swiss Parliament Rejects Gold Standard Initiative Pending Popular Vote
Federal Program Supplies Surplus Military Gear to Schools
Bank of England Says Government Should Split Up RBS, Accept Loss
Marine in tutu allegedly mistakes vet's wheelchair as costume, assaults him
European central banks mull bolder moves to prevent low inflation
From Walmart To Bitcoin: The CEO Behind The Chinese Exchange
Beef, big bucks and buy-ups: are Chinese investors changing the face of Australia?
Bitcoin moves beyond mere money
Egypt’s army threatens to ‘intervene’ if unrest continues
Bitcoin Believers See a Role for Wall Street
Leland cop suspended after arresting man for recording another arrest